Announced Thu, 27 Nov · 18:19 IST

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

MEDPLUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

This NSE filing from Medplus Health Services Limited references Regulation 30 of the SEBI Listing Regulations, which is the general disclosure rule companies must follow when reporting material events or updates to the stock exchanges. However, the actual content of the update — i.e., what specific event, decision, or change is being disclosed — has not been provided in the available text. No key numbers, financial figures, dates, or event details are available to summarise. Without the body of the filing, it is not possible to determine whether this relates to a board decision, change in management, a new contract, a regulatory action, or any other corporate development.

Likely market impact

No impact on shareholders or the stock can be assessed from this filing alone, since the substantive details of the disclosure are missing. Investors should look for the full announcement or a follow-up filing from Medplus to understand what was reported.